Needham & Company
-
After-Hours Stock Movers 07/15: (AEHR) (APT) (MRNA) Higher; (AOUT) (CRVS) Lower (more...)
-
UPDATE: Needham & Company Starts Taysha Gene Therapies (TSHA) at Buy, $45 PT
-
Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences